Document is current
Any future updates will be listed below
-
Authors
Colussi, Claudia https://orcid.org/0000-0002-7727-8911
Bertozzi, Alessia
Leone, Lucia
Rinaudo, Marco
Sollazzo, Raimondo
Conte, Federica
Paccosi, Elena
Nardella, Luca
Aceto, Giuseppe
Li Puma, Domenica Donatella
Ripoli, Cristian
Vita, Maria Gabriella
Marra, Camillo
D’Ascenzo, Marcello
Grassi, Claudio
-
Funding
Funding for this research was provided by:
Alzheimer’s Association (AARG-19 614919)
- License Information
-
More Information
Article History
Received: 5 October 2023
Accepted: 17 June 2024
First Online: 3 September 2024
Change Date: 5 December 2024
Change Type: Update
Change Details: Author, Domenica Donatella Li Puma’s Family Name was corrected.
Declarations
:
: All animal procedures were approved by the Ethical Committee of the Università Cattolica del Sacro Cuore and were fully compliant with Italian (Ministry of Health guidelines, Legislative Decree No. 116/1992) and European Union (Directive No. 86/609/EEC) legislations on animal research.Isolation and culture of skin fibroblasts from patients and iPSC generation were performed in accordance to the international standard of GCP (Legislative Decree D.M. 15 July 1997) with the ethical permit granted by the Fondazione Policlinico Gemelli Ethic Committee (protocol #0040217 dated 16/11/2021, title: Production of human inducible pluripotent stem cells from peripheral tissue of Alzheimer’s disease patients to study disease progression and therapeutic potential of new biotechnological approaches. Written patient’s informed consents to participate to the study were obtained before procedures.
: Not applicable.
: The authors declare no conflict of interest.
